Ypsomed AG, Burgdorf acquires 10 % equity stake in Bionime Corp. Bionime Corporation proudly announces a joint co-operation with Ypsomed AG, Switzerland. Ypsomed is a worldwide leading independent developer and manufacturer of injection systems for custom-made self-administration and supplier of…
Bionime GM100 series acquires “Innovation Award” from Mediphar Taipei 8 winners chosen from a pool of 39 candidates! Bionime RightestTMGM100 series acquires “Innovation Award” from Mediphar Taipei and becoming the only one winner who targets the field of Self-Monitoring Blood Glucose…
Got USA FDA 510(k) clearance letter (K081450) (Rightest Blood Glucose Monitoring System, Model GM110 ) Got USA FDA 510(k) clearance letter (K081450) (Rightest Blood Glucose Monitoring System, Model GM110 )
Got Taiwan Certificate of Good Design Product (Rightest Blood Glucose Monitoring System, Model GD500). Got Taiwan Certificate of Good Design Product (Rightest Blood Glucose Monitoring System, Model GD500).
Got approval of initial public offering form Securities and Futures Bureau (Stock No.4737). Got approval of initial public offering form Securities and Futures Bureau (Stock No.4737).
Renew Taiwan GMP certificate Renew Taiwan GMP certificate
Got China SFDA Medical Device certificate (Rightest Blood Glucose Meter, Model GM300/GM210). Got China SFDA Medical Device certificate (Rightest Blood Glucose Meter, Model GM300/GM210).
Got Taiwan Medical Device certificate (Rightest Blood Glucose Monitoring System, Model GM100). Got Taiwan Medical Device certificate (Rightest Blood Glucose Monitoring System, Model GM100).
Gradually phase in GD500 for worldwide distributors. Gradually phase in GD500 for worldwide distributors.
Launch GM101 No Coding Blood Glucose Monitoring System with whole blood calibrated reading to Germany. Launch GM101 No Coding Blood Glucose Monitoring System with whole blood calibrated reading to Germany.